Sign In
Free Newsletter
Jersey City officials push to stop Heights Hospital ER closure (updated)
Officials condemn the planned March 14 closure of Heights University Hospital ER by Hudson Regional health, citing risks to community health and urging state intervention.
NJ pharma drugs among 15 targeted in Medicare price talks (updated)
CMS targets 15 high-spend drugs for Medicare price negotiations, including therapies from New Jersey-based Novartis, Johnson & Johnson and Bristol Myers Squibb.
Murphy’s final medical debt relief round brings total to $1.5B
Gov. Phil Murphy announced the latest phase of New Jersey’s medical debt relief initiative, eliminating nearly $16 million for 14,000 residents.
NJ wipes $86M in medical debt for 53,000 residents
The state's sixth round of forgiveness erased $86 million through Undue Medical Debt, bringing the program total to nearly $1.4 billion.
BioNJ’s Hart on policy, AI and what’s next for NJ life sciences
NJBIZ continues the conversation with CEO Debbie Hart, who discusses tariffs, technology, manufacturing and the most exciting developments in the industry.
